TTK Healthcare Limited (TTKHLTCARE) Price & Analysis

Compare

0 Followers

TTKHLTCARE Stock Chart & Stats

₹1029.00

₹5.50(0.40%)

At close: Jan 08 4:00 PM EST

₹1029.00

₹5.50(0.40%)

Day’s Range― - ―

52-Week Range₹807.00 - ₹1,402.00

Previous CloseN/A

Volume1.55K

Average Volume (3M)82.00

Market Cap

₹11.48B

Enterprise Value₹5.74B

Total Cash (Recent Filing)₹6.01B

Total Debt (Recent Filing)₹285.86M

Price to Earnings (P/E)34.8

Beta0.78

Next Earnings

May 22, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.95%

Share Statistics

EPS (TTM)7.45

Shares Outstanding14,130,333

10 Day Avg. Volume50

30 Day Avg. Volume82

Financial Highlights & Ratios

PEG Ratio0.68

Price to Book (P/B)1.57

Price to Sales (P/S)1.91

P/FCF Ratio-99.33

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage & Strong ROEA low debt-to-equity profile and strong equity base reduce refinancing and solvency risk, giving the company durable financial flexibility. High ROE indicates efficient use of capital, supporting sustained reinvestment into R&D, distribution, or product expansion over the medium term.

Consistent Revenue Growth With Robust Gross MarginsSustained revenue growth alongside robust gross margins points to steady demand and effective cost control at the production level. This combination supports long-term cash generation potential and the ability to fund marketing, expand brands, and maintain pricing power versus peers.

Diversified Healthcare Product PortfolioA mixed portfolio across pharmaceuticals, consumer healthcare, and medical devices reduces revenue concentration and smooths cyclicality across channels. Multiple go-to-market routes (domestic distribution, institutional sales, exports) support resilient demand and cross-selling opportunities over 2–6 months.

Bears Say

Negative Operating And Free Cash FlowNegative operating and free cash flows indicate weak cash conversion despite accounting profits. Persisting cash deficits constrain the firm's ability to self-fund capex, acquisitions, or shareholder returns, raising dependence on external financing and limiting strategic flexibility over the medium term.

Declining EBITDA MarginA falling EBITDA margin signals deteriorating operating leverage or rising input and operating costs. If sustained, margin erosion will reduce operating cash flow, weaken competitive cost positioning, and limit room for investment in brands or distribution, pressuring long-term profitability.

Negative EPS Growth / Earnings PressureMaterial negative EPS growth reflects earnings stress that may stem from margin compression, expenses, or non-recurring items. Continued EPS declines reduce retained earnings available for reinvestment, heighten performance volatility, and may impede execution of multi-quarter strategic initiatives.

TTK Healthcare Limited News

TTK Healthcare Seeks Shareholder Nod via E-Voting to Appoint New Independent Director

TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) has issued an announcement. TTK Healthcare Limited has launched a postal ballot...

3M ago

TTK Healthcare Board Appoints New Independent Director, Seeks Shareholder Nod via Postal Ballot

An update from TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) is now available. TTK Healthcare Limited’s board has approved...

3M ago

TTKHLTCARE FAQ

What was TTK Healthcare Limited’s price range in the past 12 months?

TTK Healthcare Limited lowest stock price was ₹807.00 and its highest was ₹1402.00 in the past 12 months.

What is TTK Healthcare Limited’s market cap?

TTK Healthcare Limited’s market cap is ₹11.48B.

When is TTK Healthcare Limited’s upcoming earnings report date?

TTK Healthcare Limited’s upcoming earnings report date is May 22, 2026 which is in 61 days.

How were TTK Healthcare Limited’s earnings last quarter?

TTK Healthcare Limited released its earnings results on Jan 22, 2026. The company reported ₹7.454 earnings per share for the quarter, beating the consensus estimate of N/A by ₹7.454.

Is TTK Healthcare Limited overvalued?

According to Wall Street analysts TTK Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does TTK Healthcare Limited pay dividends?

TTK Healthcare Limited pays a Annually dividend of ₹10 which represents an annual dividend yield of 0.95%. See more information on TTK Healthcare Limited dividends here

What is TTK Healthcare Limited’s EPS estimate?

TTK Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TTK Healthcare Limited have?

TTK Healthcare Limited has 14,130,333 shares outstanding.

What happened to TTK Healthcare Limited’s price movement after its last earnings report?

TTK Healthcare Limited reported an EPS of ₹7.454 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.839%.

Which hedge fund is a major shareholder of TTK Healthcare Limited?

Currently, no hedge funds are holding shares in IN:TTKHLTCARE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

TTK Healthcare Limited

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.